Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

Completed · Phase 3

Conditions studied: Ulcerative Colitis

In brief

This study assesses the long-term safety and efficacy of adalimumab in pediatric subjects with ulcerative colitis.

Key facts

Study ID
NCT02632175
Run by
AbbVie
People needed
59
Starts
2015-11-26
Expected to finish
2025-04-08
Last updated by the study team
2025-10-16

Who can join

Age: 4 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.